FI67545C - Foerfarande foer framstaellning av ett farmakologiskt aktivt imidazolinderivat - Google Patents

Foerfarande foer framstaellning av ett farmakologiskt aktivt imidazolinderivat Download PDF

Info

Publication number
FI67545C
FI67545C FI822551A FI822551A FI67545C FI 67545 C FI67545 C FI 67545C FI 822551 A FI822551 A FI 822551A FI 822551 A FI822551 A FI 822551A FI 67545 C FI67545 C FI 67545C
Authority
FI
Finland
Prior art keywords
alkyl
formula
hydrogen
methyl
compound
Prior art date
Application number
FI822551A
Other languages
English (en)
Finnish (fi)
Other versions
FI822551A0 (fi
FI67545B (fi
FI822551L (fi
Inventor
Christopher Bourne Chapleo
Peter Leslie Myers
Original Assignee
Reckitt & Colmann Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt & Colmann Prod Ltd filed Critical Reckitt & Colmann Prod Ltd
Publication of FI822551A0 publication Critical patent/FI822551A0/fi
Publication of FI822551L publication Critical patent/FI822551L/fi
Publication of FI67545B publication Critical patent/FI67545B/fi
Application granted granted Critical
Publication of FI67545C publication Critical patent/FI67545C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/14Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by free hydroxyl radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D307/85Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
FI822551A 1981-07-28 1982-07-20 Foerfarande foer framstaellning av ett farmakologiskt aktivt imidazolinderivat FI67545C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8123271 1981-07-28
GB8123271 1981-07-28

Publications (4)

Publication Number Publication Date
FI822551A0 FI822551A0 (fi) 1982-07-20
FI822551L FI822551L (fi) 1983-01-29
FI67545B FI67545B (fi) 1984-12-31
FI67545C true FI67545C (fi) 1985-04-10

Family

ID=10523561

Family Applications (1)

Application Number Title Priority Date Filing Date
FI822551A FI67545C (fi) 1981-07-28 1982-07-20 Foerfarande foer framstaellning av ett farmakologiskt aktivt imidazolinderivat

Country Status (24)

Country Link
US (1) US4411908A (es)
EP (1) EP0071368B1 (es)
JP (1) JPS5826884A (es)
AT (1) ATE12769T1 (es)
AU (1) AU549166B2 (es)
CA (1) CA1171864A (es)
CS (1) CS229938B2 (es)
DD (1) DD211349A5 (es)
DE (1) DE3263123D1 (es)
DK (1) DK160275C (es)
ES (1) ES514359A0 (es)
FI (1) FI67545C (es)
GR (1) GR76210B (es)
HU (1) HU190023B (es)
IE (1) IE53389B1 (es)
IL (1) IL66353A (es)
NO (1) NO157215C (es)
NZ (1) NZ201219A (es)
PH (1) PH18878A (es)
PL (1) PL139439B1 (es)
PT (1) PT75329B (es)
SU (1) SU1204134A3 (es)
ZA (1) ZA825164B (es)
ZW (1) ZW13782A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2539415B1 (fr) * 1983-01-14 1985-09-13 Adir Derives de la d-2 imidazoline, leur preparation et leur application en therapeutique
EP0141686B1 (fr) * 1983-08-11 1987-09-09 Synthelabo Dérivés de l'indole, leur préparation et leur application en thérapeutique
EP0139584B1 (fr) * 1983-10-17 1988-05-18 Synthelabo Dérivés d'imidazoline, leur préparation et leur application en thérapeutique
KR910005851B1 (ko) * 1983-12-12 1991-08-05 신 떼라보 피롤로[3,2,1-hi]인돌유도체 및 약학적으로 허용되는 그의 산부가염을 제조하는 방법
FR2621486B1 (fr) * 1987-10-07 1990-01-26 Synthelabo Utilisation de derives de pyrrolo(3,2,1-hi)indole pour obtenir un medicament destine au traitement du diabete
GB2167408B (en) * 1984-11-23 1988-05-25 Farmos Oy Substituted imidazole derivatives and their preparation and use
US4666931A (en) * 1984-12-29 1987-05-19 Kaken Pharmaceutical Co., Ltd. Benzofuran derivatives useful in treating diabetic complications
US4895867A (en) * 1986-06-26 1990-01-23 Norwich Eaton Pharmaceuticals, Inc. 2-(5-phenyl-2-furanyl)imidazoles useful as cardiotonic agents
US4882343A (en) * 1987-08-28 1989-11-21 G. D. Searle & Co. Biarylalkylimidazole derivatives as anti-depressants
DK344489D0 (da) * 1989-07-12 1989-07-12 Novo Nordisk As Substituerede 2-imidazoliner og fremstilling og anvendelse deraf
GB9020128D0 (en) * 1990-09-14 1990-10-24 Reckitt & Colmann Prod Ltd Imidazoline derivatives
GB9127050D0 (en) * 1991-12-20 1992-02-19 Orion Yhtymae Oy Substituted imidazole derivatives and their preparation and use
GB9127430D0 (en) * 1991-12-27 1992-02-19 Scras Benzofuranylimidazole derivatives
FR2706303B1 (fr) * 1993-06-18 1995-09-08 Pf Medicament Utilisation de l'Efaroxan et de ses dérivés pour la préparation d'un médicament destiné au traitement de la maladie de Parkinson.
FR2707166B1 (fr) * 1993-07-09 1995-09-29 Pf Medicament Utilisation de l'efaroxan et de ses dérivés pour la fabrication de médicaments destinés au traitement de maladies neurodégénératives et leur progression .
WO1999032482A1 (en) * 1997-12-19 1999-07-01 Eli Lilly And Company Hypoglycemic imidazoline compounds
FR2784989B1 (fr) * 1998-09-10 2002-09-27 Fabre Pierre Sante Derive d'ester d'acide 2-ethyl-2,3-dihydrobenzofurane- carboxylique, procede de preparation et utilisation pour la preparation de derives de l'efaroxan
AU5319700A (en) * 1999-06-02 2000-12-18 S. Mbua Ngale Efange Nicotine receptor ligands
SE9902267D0 (sv) * 1999-06-16 1999-06-16 Astra Ab New compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2168216A1 (en) * 1972-01-21 1973-08-31 Labaz Substd imidazolines - with vasoconstrictor activity
US3927023A (en) * 1974-05-24 1975-12-16 Warner Lambert Co Imidazolyl benzofurans
DE2933962A1 (de) * 1979-08-22 1981-03-26 Hoechst Ag, 65929 Frankfurt Verfahren zur herstellung von 4,5-dichlor-imidazolen.

Also Published As

Publication number Publication date
DE3263123D1 (de) 1985-05-23
JPS5826884A (ja) 1983-02-17
NO157215B (no) 1987-11-02
ZW13782A1 (en) 1982-10-06
SU1204134A3 (ru) 1986-01-07
ZA825164B (en) 1983-05-25
NZ201219A (en) 1984-10-19
IL66353A (en) 1985-08-30
DD211349A5 (de) 1984-07-11
CS229938B2 (en) 1984-07-16
IE821789L (en) 1983-01-28
DK160275B (da) 1991-02-18
NO822568L (no) 1983-01-31
FI822551A0 (fi) 1982-07-20
DK160275C (da) 1991-07-22
PH18878A (en) 1985-10-22
IL66353A0 (en) 1982-11-30
PT75329A (en) 1982-08-01
ES8307796A1 (es) 1983-08-01
AU549166B2 (en) 1986-01-16
US4411908A (en) 1983-10-25
PT75329B (en) 1984-07-31
FI67545B (fi) 1984-12-31
JPH0233038B2 (es) 1990-07-25
CA1171864A (en) 1984-07-31
HU190023B (en) 1986-08-28
EP0071368B1 (en) 1985-04-17
ATE12769T1 (de) 1985-05-15
FI822551L (fi) 1983-01-29
DK335682A (da) 1983-01-29
IE53389B1 (en) 1988-10-26
AU8643882A (en) 1983-06-02
ES514359A0 (es) 1983-08-01
PL237655A1 (en) 1983-03-28
EP0071368A1 (en) 1983-02-09
PL139439B1 (en) 1987-01-31
GR76210B (es) 1984-08-03
NO157215C (no) 1988-02-10

Similar Documents

Publication Publication Date Title
FI67545C (fi) Foerfarande foer framstaellning av ett farmakologiskt aktivt imidazolinderivat
US5955495A (en) Method of treating diseases of the CNS
Chapleo et al. . alpha.-Adrenoceptor reagents. 2. Effects of modification of the 1, 4-benzodioxan ring system on. alpha.-adrenoreceptor activity
NO862159L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heteroaromatiske aminderivater.
FI71734C (fi) Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara isokinolinderivat.
FI67543C (fi) Foerfarande foer framstaellning av farmakologiskt aktiv 2-(2-(1,4-benzodioxanyl))-2-imidazolin
NO167658B (no) Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive difenylpropylaminderivater.
US4156732A (en) Certain pharmaceutical sulfamoylbenzoyl benzofurans, benzothiophenes, and indoles
NO860285L (no) Fremgangsmaate ved fremstilling av imidazolderivater.
WO1995029911A1 (en) Benzofuran derivatives as d4 receptor antagonists
FI67544B (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefullt imidazolinderivat
US4446148A (en) Benzodioxanyl imidazoline compounds, compositions and use
FR2558835A1 (fr) Derives d'hydantoine, leur procede de production et medicament les contenant
FR2634207A1 (fr) Derives de ((piperidinyl-4)methyl) benzazepines, leur preparation et leur application en therapeutique
EP1192152B1 (fr) Nouveaux derives benzodioxanne imidazolines fluores, leur preparation et leurs applications en therapeutique
CA2071398A1 (en) Aminomethyl-substituted 2,3-dihydropyrano/2,3-b/pyridines, process for their preparation and their use in medicaments
GB2102422A (en) Imidazoline derivatives
NO153729B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heksahydro-trans-4a,9b-1(h)pyridoindolderivater.
FI64142B (fi) Foerfarande foer framstaellning av nya terapeutiskt aktiva benso(c)kinolinonderivat
KR820002297B1 (ko) 염소환된 테트라히드로-2-벤즈아제핀류의 제조방법
MXPA02005019A (es) Derivados de 2-arilquinolina, preparacion y uso terapeutico de los mismos.
DK151332B (da) Analogifremgangsmaade til fremstilling af dibenzoxazonin-, dibenzoxazecin- eller dibenzoxaazacykloundecanderivater eller de tilsvarende thia- eller azaderivater eller farmaceutisk acceptable syreadditionssalte deraf

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: PIERRE FABRE MEDICAMENT SA

MM Patent lapsed

Owner name: PIERRE FABRE MEDICAMENT SA